-
Welcome to Celiac.com!
You have found your celiac tribe! Join us and ask questions in our forum, share your story, and connect with others.
-
Celiac.com Sponsor (A1):
Celiac.com Sponsor (A1-M):
-
Get Celiac.com Updates:Support Our Content
Search the Community
Showing results for tags 'fasano'.
-
Celiac.com 06/13/2024 - Clinically speaking, celiac disease is a chronic gluten-sensitive immune-mediated disorder that primarily affects the small intestinal mucosa. Celiac disease arises in individuals with the human leukocyte antigen (HLA) DQ2 and/or DQ8 alleles; after they consume gluten, such persons can experience a host of deleterious clinical symptoms, from the gastrointestinal to the neurologic. Despite having been first identified in ancient Greece, much of what we know about celiac disease comes from the past few decades, when a dogged group of epidemiologists and researchers began tracing its millennia-old path around the globe. This presentation charts their hard work and how a once obscure but increasingly prevalent disease improbably birthed the biggest diet trend going. The Long Roots of Celiac Disease Mankind's turn toward agricultural practices around 10,000 years ago provided the conditions upon which human civilization was built; it also represented a radical schism in terms of what we put in our bodies. From a hunter/gatherer diet of meat and foraged fruits and vegetables, our digestive systems suddenly had to contend with a new item on the menu: gluten. A storage protein that allows certain flowering plants to nourish their seeds, gluten is found in such grains as wheat, barley, and rye. Although gluten-containing plants took several thousands of years to spread across the globe, from an evolutionary point of view, it occurred in the blink of an eye. This effect was compounded by the fact that the gluten content of available grain varieties has notably increased within the past 500 years, leading to theories that our immune systems were not given sufficient time to develop adaptive mechanisms to process the "new" substance. Celiac Disease Earns a Name, and War Reveals its Triggers The first-known description of celiac disease comes from nearly 2,000 years ago, via the Greek physician Aretaeus of Cappadocia. In discussing a patient with symptoms that included diarrhea and malabsorption, Aretaeus used the term "coeliac," from the Greek "koiliakos" or "abdominal." A full description of celiac disease would not appear in the literature until the late 19th century, when the London-based physician Samuel Gee reported its appearance, primarily in young children aged 1-5 years who presented with chronic indigestion. Gee correctly understood celiac disease to be caused by food-related malabsorption, and recommended dietary intervention consisting of—unfortunately—toast. The next major breakthrough would occur through a combination of serendipity and disaster. As World War II raged on, disruptions to the food supply ravaged the Netherlands, making wheat a rare commodity. The Dutch pediatrician Willem Karel Dicke observed a corresponding drop in mortality among children with celiac disease, thereby making the causative link that would jumpstart the gluten-free diet, the main therapeutic intervention to this day. Searching for Celiac As detailed in the book Gluten Freedom, by Alessio Fasano, MD, the global search for answers that followed Dicke's observation was launched from an erroneous assumption that this condition primarily affected children from Northern Europe. The underlying theory was that natural selection had eliminated the disease from regions where agriculture first appeared. Beginning in the 1990s, pioneering epidemiologic work upended notions that celiac disease was not a global disease. By the end of the decade, celiac disease had been identified in countries extending from Italy to India, and has now been observed in nearly every corner of the world where gluten is consumed. Yet even in the current day, the role that geographic region plays in celiac disease remains debated. A recent study even found the prevalence to be higher among those in northern latitudes of the United States than in their counterparts to the south. "It is possible that geographic and environmental differences, particularly feeding habits, may dictate the final onset and clinical presentation of celiac disease that may account for this apparent difference as reported by this study," said Dr Fasano, the W. Allan Walker Chair of Pediatric Gastroenterology and Nutrition Professor of Pediatrics at Harvard Medical School. The North American Puzzle As epidemiologic researchers planted the flag of across the globe, one region proved surprisingly impervious to their efforts. Despite having all the conditions necessary for it to occur, including an abundance of gluten-based products, celiac disease was considered exceptionally rare in North America in the early 1990s. Dr Fasano and his colleagues set out to solve the puzzle of just why this was. At the risk of what Dr Fasano describes in his book as "professional suicide," they procured 2000 blood samples from the American Red Cross and tested them for autoantibodies to celiac disease. The investment paid off, with their findings moving the disease from the status of "rare" to one with a prevalence then believed to be closer to 1 in 250. Several years later, a greatly expanded epidemiologic study from this team indicated that the prevalence of celiac disease was as high as 1 in 133, in line with figures from Europe at that time. With their efforts, a missing piece of the map fell into place, and celiac disease's status as a global disease was secured. Looking for Answers Because celiac disease can present subclinically, with limited or even no intestinal symptoms, it can be difficult to pin down. Confounding earlier notions of the disease, celiac disease now presents more often without malabsorptive symptoms or malnutrition, and affects both underweight patients and overweight patients at approximately the same rate. What was also once thought to be a disease diagnosed mainly among pediatric patients is now seen at a much higher rate of 9 to 1 in adults between the fourth and sixth decades of life. Yet young patients with celiac disease still present specific concerns, with evidence suggesting that they experience psychiatric conditions at approximately 1.5 times the rate of the general population. "This probably represents a paradigm of the gut/brain axis, with two-way crosstalk between these two organs," said Dr Fasano. "Pediatric patients who present with symptoms that include anxiety, depression, attention-deficit/hyperactivity disorder, or even autism deserve special attention, particularly in monitoring these symptoms after implementation of a gluten-free diet." Celiac Disease Rates Continue to Rise The conditions required for celiac disease to manifest itself are ever-thriving, supported by an increasing dietary reliance on gluten-based foods. Furthermore, the transition from hunter/gatherer society to mass-produced agriculture is not solely a vestige of history, but continues to this day among indigenous tribes, such as those of the Coast Salish First Nations population of western Canada. Further exposure to gluten is expected in fast-growing economies such as China, where the Western diets that are currently in vogue are expected to lead to an uptick in celiac disease. How High Can Celiac Rates Go? If the celiac disease research community's past half-century was primarily spent getting their colleagues to accept that this was a disease with a global footprint, the coming years will probably be spent determining its full impact. It is estimated that as many as 7 out of 8 people with celiac disease have not been diagnosed. If true, this would represent a notable unrepresented cohort for a disease that has already seen its prevalence rate surge since the 1950s. "Previous studies from our group and others suggest a doubling of celiac disease prevalence every 15 years," said Dr Fasano. "When a long-enough surveillance of time has been performed, similar data have been reported in Europe. Indeed, no signs of a celiac disease plateau have been reported in Europe, despite good awareness around the disease and the fairly widespread adoption of the gluten-free diet as an effective medical treatment for celiac disease." Celiac Disease Triggers a Dietary Trend As the prevalence in the general population, and the profile of celiac disease within the medical community began to rise, so too did a strange, and probably related, phenomenon: the popularity of the gluten-free diet among the general public. Like all dietary trends before it, the origins are hard to source, although the factor that accelerated it is certainly not. "The gluten-free diet has been indisputably fueled by its adoption by high-profile people, particularly actresses, actors, and sports champions," said Dr Fasano. The 2015 book The Gluten Lie noted that this is not the first time that celiac disease may have birthed a dietary craze. In the 1920s, doctors in the United States recommended that their patients with celiac disease subsist on bananas and milk, thinking that special enzymes were responsible for their marked improvement. A decade later, this diet had skipped out of the clinic and into the mainstream as a fashionable means for taking off the pounds. Gluten-Free Dietary Burden Shrinks as Options Expand A study published in 2005 that was based on interviews with patients with celiac disease reported that their lives were substantially influenced by feelings of shame, isolation, and fear, given their limited ability to find foods that they could safely consume. In the intervening years, the improbable rise of gluten-free diets has rendered this study a relic of the past. With upward of 5% of the population thought to now be following gluten-free diets, supermarkets and restaurants are suddenly awash in offerings for those with celiac disease, wheat allergies, or non-celiac gluten sensitivity. However, the majority of people driving this trend have no medical necessity for adopting a gluten-free diet, a fact that may carry its own health risks. What's Next for Celiac Disease? We may be in the grip of a gluten-free diet boom, but according to Dr Fasano, there has not been a trickle-down effect when it comes to funding for celiac research. "Funding was almost nonexistent 15 years ago, and it remains extremely low to date," he said. "Nevertheless, the interest of the research community into celiac disease as a model of autoimmunity has indisputably increased." He added that researchers are now looking at , and in particular its key genetic component (HLA DQ2/DQ8) and environmental trigger (gluten), as a means for understanding other chronic inflammatory diseases. Dr Fasano and his colleagues are currently conducting the prospective Celiac Disease Genomic Environmental Microbiome and Metabolomic Study. Time will tell what its findings may add to our understanding of this ever-evolving disease that's been many thousands of years in the making. Read more at: medscape.com
- 1 comment
-
- celiac disease
- development
-
(and 3 more)
Tagged with:
-
Celiac.com 09/01/2002 - Patients with celiac disease are 20 times more likely than the general population to have epilepsy and often have associated cerebral and cerebellar calcifications imaged by CT and MRI. Depression, dementia, and schizophrenia are all also common in persons with untreated celiac disease. Cerebellar degeneration with resulting ataxia (gluten-associated ataxia) is a known entity in Europe, and the National Institutes of Health (NIH) is currently recruiting subjects with ataxia to examine them for gluten sensitivity and celiac disease. Focal white matter lesions in the brain recently have been reported to occur in children with celiac disease and are thought to be either ischemic in origin as a result of vasculitis or caused by inflammatory demyelination. Parents of children with celiac disease have reported behavioral changes such as irritability, separation anxiety, emotional withdrawal, and autistic-like behaviors that all seemed to improve on a GFD. Although not scientifically validated, the GFD is now also being advocated for children with autism by several groups. Whether or not children with autism are at a higher risk for celiac disease or celiac children have a higher incidence of autism remains to be proven. However, children with Down syndrome, who often have autistic-like behaviors, are at higher risk for celiac disease. It has been hypothesized that gluten may be broken down into small peptides that may cross the blood-brain barrier and interact with morphine receptors, leading to alterations in conduct and perceptions of reality. The serologic tests can be divided into 4 different types of antibodies: antigliadin (AGA), antireticulin, antiendomysium (AEA), and antitissue transglutaminase (tTG). Each antibody varies widely in its sensitivity, specificity, and positive and negative predictive values (Table 2). Table 2 (from Pietzak et al, 2001, compiled data from multiple studies) Test Sensitivity Specificity PPV NPD AGA IgG 57-100 42-98 20-95 41-88 AGA IgA 53-100 65-100 28-100 65-100 AEA IgA* 75-98 96-100 98-100 80-95 Guinea pig tTG† 90.2 95 Human tTG† 98.5 98 * Patients older than 2 years of age. † IgG +IgA antibodies. The AEA IgA immunofluorecent antibody is an excellent screening test for celiac disease, with both a high sensitivity and specificity. This antibody was discovered in the early 1980s and rapidly gained use as part of a screening celiac panel by commercial laboratories in combination with AGA IgG and AGA IgA. Its major drawbacks are that it may be falsely negative in children under the age of 2 years, in patients with IgA deficiency, and in the hands of an inexperienced laboratory. Also, the substrate for this antibody was initially monkey esophagus, making it expensive and unsuitable for screening large numbers of people. Recently, the human umbilical cord has been used as an alternative to monkey esophagus. However, the subjective nature of the AEA assay may lead to false-negative values and unacceptable variability between laboratories. Because tTG had been first described as the autoantigen of celiac disease in 1997, it has been used to develop innovative diagnostic tools. The tTG IgA ELISA test is highly sensitive and specific, using either the commercially available guinea pig tTG or human recombinant tTG. The tTG assay correlates well with AEA-IgA and biopsy. However, it represents an improvement over the AEA assay because it is inexpensive and rapid (30 minutes), is not a subjective test, and can be performed on a single drop of blood using a dot-blot technique. Therefore, this test is ideally suited for mass screenings and in the future could be performed in the general practitioners office, much like the now routine finger-stick hematocrit. For the reasons outlined above, the IgA class human anti-tTg antibody, coupled with the determination of total serum IgA, currently seems to be the most cost-effective way to screen for celiac disease. AEA should be used as a confirmatory, pre-biopsy test, whereas AGA determinations should be restricted to the diagnostic work-up of younger children and patients with IgA deficiency, using the guidelines in Table 3. Table 3 Probability of celiac disease based on three antibodies in combination AEA IgA AGA IgA AGA IgG Interpretation + + + Celiac disease 99% probable + - + probable + + - Celiac disease probable + - - Celiac disease probable - + + Celiac disease less likely* - - + Celiac disease less likely* - + - Celiac disease less likely - - - Celiac disease very unlikely+ * If patient is IgA sufficient: AGA IgG > 100 warrants work-up of enteropathy. + If patient is on a gluten-containing diet. Celiac disease: AEA, antiendomysium antibodies: AGA, antigliadin antibodies.
Celiac.com Sponsor (A8):
Celiac.com Sponsor (A8):
Celiac.com Sponsor (A8-M):